Potential first-in-class treatment is well-tolerated in patients with chronic hepatitis B
New data presented today confirms that a novel first-in-class treatment for Hepatitis B, called NVR 3-778, is well-tolerated and can reduce levels of the virus' genetic material in the body when combined with pegylated interferon ...
Apr 16, 2016
0
15